Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technique
1.1.2. Indication
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technique outlook
2.2.2. Indication outlook
2.2.3. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Magnetic Resonance Angiography Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. U.S. Magnetic Resonance Angiography Market Analysis Tools
3.4.1. Industry Analysis – Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. U.S. Magnetic Resonance Angiography Market: Technique Estimates & Trend Analysis
4.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
4.2. U.S. Magnetic Resonance Angiography Market: Technique Movement & Market Share Analysis, 2022 & 2030
4.3. Contrast-Enhanced MRA
4.3.1. Contrast-Enhanced MRA market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Non-contrast Enhanced MRA
4.4.1. Non-contrast Enhanced MRA market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Magnetic Resonance Angiography Market: Indication Estimates & Trend Analysis
5.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
5.2. U.S. Magnetic Resonance Angiography Market: Indication Movement & Market Share Analysis, 2022 & 2030
5.3. Abdomen
5.3.1. Abdomen market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Lower Extremities
5.4.1. Lower extremities market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Magnetic Resonance Angiography Market: End-use Estimates & Trend Analysis
6.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
6.2. U.S. Magnetic Resonance Angiography Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Imaging Centers
6.4.1. Imaging centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers and Other Healthcare Settings
6.5.1. Ambulatory Surgical Centers and Other Healthcare Settings market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. GE Healthcare
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Koninklijke Philips N.V.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Siemens Healthcare GmbH
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Hitachi, Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Canon, Inc.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Shenzhen Anke Hi-Tech Co., Ltd.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Time Medical Holding
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. ASG Superconductors SpA
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Neusoft Corporation
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Shimadzu Corporation
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. ESAOTE SpA
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. AllTech Medical Systems
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. CentraCare
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Radiology Associates of Ocala
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. Hunt Regional Healthcare
7.2.15.1. Company overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
7.2.16. Montgomery Radiology Associates
7.2.16.1. Company overview
7.2.16.2. Financial performance
7.2.16.3. Product benchmarking
7.2.16.4. Strategic initiatives